Antiemetic Efficacy and Safety of Dexamethasone in Obstetric Surgical Patients
NCT ID: NCT01028547
Last Updated: 2010-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
250 participants
INTERVENTIONAL
2010-01-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexamethasone Compared to Ondansetron and Dexamethasone for Prophylaxis of Postoperative Vomiting in Children
NCT01297010
Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting
NCT01975727
Dexamethasone Dose for Postoperative Nausea and Vomiting Prophylaxis in Obese Patients
NCT04538820
The Effect of Prophylactic Antiemetic Dexamethasone on Plasma Cortisol Levels
NCT01524731
Effect of Dexamethasone Combined With Ondansetron on Postoperative Nausea and Vomiting in Patients With Patient-controlled Analgesia After Video-assisted Thoracoscopic Surgery
NCT01007500
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dexamethasone 8mg
dexamethasone
single Bolus dose of dexamethasone 8mg
normal saline
normal saline
2 ml 0.9% saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dexamethasone
single Bolus dose of dexamethasone 8mg
normal saline
2 ml 0.9% saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* younger than 18 years old,
* hypertensive,
* diabetic,
* preeclamptic,
* sepsis,
* ASAIIIE plus.
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Makerere University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of anaesthesia Makerere University College of health sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tindimwebwa J V B, MD
Role: STUDY_DIRECTOR
Makerere university dept of anesthesia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mulago National Refferal Hospital
Kampala, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Griffiths JD, Gyte GM, Popham PA, Williams K, Paranjothy S, Broughton HK, Brown HC, Thomas J. Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section. Cochrane Database Syst Rev. 2021 May 18;5(5):CD007579. doi: 10.1002/14651858.CD007579.pub3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PONVDEX
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.